Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: A report of 50 patients;5-Fluorouracile bimensuel en traitement du cancer colorectal metastase chez le sujet age. Etude de 50 patients

Revue de Medecine Interne

Volumn 20, Issue 10, 1999, Pages 863-868

  Mabro, M ^a   Gilles Amar, V ^a   Louvet, C ^a   Carola, E ^a   Maindrault Goebel, F ^a   De Gramont, A ^a   Krulik, M ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

5 fluorouracil; Chemotherapy; Colorectal cancer; Elderly; Leucovorin

Indexed keywords

FLUOROURACIL;

AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG EFFICACY; DRUG TOLERANCE; ELDERLY CARE; FEMALE; HUMAN; MALE; METASTASIS; OUTPATIENT; QUALITY OF LIFE;

EID: 0033212710     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)80091-0     Document Type: Article

References (20)

1. Faivre J, Grosclaude P, Launoy G, Arveux P, Raverdy N, Menegoz F, et al. Les cancers digestifs en France. Distribution géographique et estimation de l'incidence nationale. Gastroenterol Clin Biol 1997 ; 21 : 174-80.
2. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. J Clin Oncol 1992 ; 10 : 904-11.
3. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 1993 ; 306 : 752-5.
4. Blijham GH, Labianca R, Bleiberg H. Should patients with advanced colorectal cancer be treated with chemotherapy? Eur J Cancer 1997 ; 33 : 815-7.
5. Glimelius B, Hoffman K, Graf W, Pahlman L, Sjöden PO, for the Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. Cancer 1994 ; 73 : 556-62.
6. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 1992 ; 10 : 896-903.
7. de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Molitor JL, et al. La modulation du 5-fluorouracile par l'acide folinique dans les cancers colorectaux avancés. Rev Méd Interne 1997 ; 18 Suppl 4 : 372-8.
8. de Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer. Eur J Cancer Oncol 1988 ; 24 : 1499-503.
9. de Gramont A, Bosset JF, Milan C, Rougier P, Boucher O, Etienne PL, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A french intergroup study. J Clin Oncol 1997 ; 15 : 808-15.
10. de Gramont A, Figer A, Seymour M, Homerin M, Lebail N, Cassidy J, et al. Randomized trial of leucovorin and 5-fluorouracil with or without oxaliplatin in advanced colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1998 ; 17 : 257a.
11. Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, et al. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous in patients with advanced colorectal carcinoma. (GERCOD). Cancer 1997 ; 79 : 1100-5.
12. Tournigand C, Louvet C, de Gramont A, Lucchi E, Seitz JF, Mal F, et al. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. (GERCOD). Cancer 1997 ; 79 : 1094-9.
13. Tournigand C, de Gramont A, Louvet C, André T, Carola E, Gilles-Amar V, et al. A simplified bimonthly regimen with leucovorin and 5-fluorouracil for metastatic colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1998 ; 17 : 274a.
14. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958 ; 53 : 457-81.
15. Beretta G, Bollina R, Cozzi C, Beretta GA, for the GOAL-group. Should we consider the weekly chemotherapy with fluorouracil + racemic folinic acid a standard treatment for advanced/metastatic carcinoma of the digestive tract in elderly patients [abstract]. Proc Am Soc Clin Oncol 1997 ; 16 : 259a.
16. Chiara S, Nobile MT, Vincenti M, Barzacchi C, Sanguineti O, Gozza A, et al. Advanced colorectal cancer in elderly patients: Results of consecutive trials with FU-based chemotherapy [abstract]. Proc Am Soc Clin Oncol 1997 ; 16 : 272a.
17. Falcone A, Pfanner E, Ricci S, Bertuccelli M, Cianci C, Carrai M, et al. Oral doxifluridine in elderly patients with metastatic colorectal cancer: A multicenter phase II study. Ann Oncol 1994 ; 5 : 760-2.
18. Abad A, Navarro M, Sastre J, Marcuello E, Aranda E, Gallen M, et al. A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish group for the treatment of gastrointestinal tumors. Oncology 1997 ; 11 Suppl 10 : 53-7.
19. Garcia de Paredes M, Mel JR, Escudero P, Camps C, Montalar J, Grande C, et al. An ongoing phase II study of Tomudex (raltitrexed) in elderly patients with advanced colorectal cancer: An assessment of tolerability and clinical benefit [abstract]. Proc Am Soc Clin Oncol 1999 ; 18 : 285a.
20. Rougier P, Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998 ; 352 : 1407-12.